Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

The T-cell Lymphoma Master Repository (TCLMR): A Prospective Databank of Patients With T-cell Lymphoma With Clinical Annotation and Matched Tumor Specimens

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05978141
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:47.081302+00:00
Published At
2025-05-21T00:00:00+00:00
Record Updated At
2025-05-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["T-cell Lymphoma", "NK-Cell Lymphoma", "T-cell Prolymphocytic Leukemia", "T-cell Large Granular Lymphocytic Leukemia", "Chronic Lymphoproliferative Disorder of NK Cells", "Aggressive NK-cell Leukemia", "Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder)", "Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood", "Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form", "Hydroa Vacciniforme-Like Lymphoproliferative Disorder", "Adult T-cell Leukemia/Lymphoma", "Extranodal NK/T-cell Lymphoma, Nasal Type", "Enteropathy-associated T-cell Lymphoma", "Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma", "Intestinal T-Cell Lymphoma, Not Otherwise Specified", "Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract", "Hepatosplenic T-cell Lymphoma", "Subcutaneous Panniculitis-Like T-Cell Lymphoma", "Mycosis Fungoides", "Sezary Syndrome", "Primary Cutaneous Anaplastic Large Cell Lymphoma", "Primary Cutaneous T-cell Lymphoma", "Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma", "Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma", "Peripheral T-Cell Lymphoma, Not Otherwise Specified", "Angioimmunoblastic T-cell Lymphoma", "Follicular T-Cell Lymphoma", "Nodal Peripheral T-Cell Lymphoma With TFH Phenotype", "Anaplastic Large Cell Lymphoma, ALK-Positive", "Anaplastic Large Cell Lymphoma, ALK-negative", "Breast Implant-Associated Anaplastic Large Cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-05-21"
protocolSection.identificationModule.nctId
"NCT05978141"
protocolSection.identificationModule.officialTitle
"The T-cell Lymphoma Master Repository (TCLMR): A Prospective Databank of Patients With T-cell Lymphoma With Clinical Annotation and Matched Tumor Specimens"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • NK-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • T-cell Prolymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • T-cell Large Granular Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Lymphoproliferative Disorder of NK Cells (protocolSection.conditionsModule.conditions)
  • Aggressive NK-cell Leukemia (protocolSection.conditionsModule.conditions)
  • Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder) (protocolSection.conditionsModule.conditions)
  • Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (protocolSection.conditionsModule.conditions)
  • Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form (protocolSection.conditionsModule.conditions)
  • Hydroa Vacciniforme-Like Lymphoproliferative Disorder (protocolSection.conditionsModule.conditions)
  • Adult T-cell Leukemia/Lymphoma (protocolSection.conditionsModule.conditions)
  • Extranodal NK/T-cell Lymphoma, Nasal Type (protocolSection.conditionsModule.conditions)
  • Enteropathy-associated T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Intestinal T-Cell Lymphoma, Not Otherwise Specified (protocolSection.conditionsModule.conditions)
  • Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract (protocolSection.conditionsModule.conditions)
  • Hepatosplenic T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Subcutaneous Panniculitis-Like T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Mycosis Fungoides (protocolSection.conditionsModule.conditions)
  • Sezary Syndrome (protocolSection.conditionsModule.conditions)
  • Primary Cutaneous Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Primary Cutaneous T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Primary Cutaneous Acral CD8-Positive T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Peripheral T-Cell Lymphoma, Not Otherwise Specified (protocolSection.conditionsModule.conditions)
  • Angioimmunoblastic T-cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Follicular T-Cell Lymphoma (protocolSection.conditionsModule.conditions)
  • Nodal Peripheral T-Cell Lymphoma With TFH Phenotype (protocolSection.conditionsModule.conditions)
  • Anaplastic Large Cell Lymphoma, ALK-Positive (protocolSection.conditionsModule.conditions)
  • Anaplastic Large Cell Lymphoma, ALK-negative (protocolSection.conditionsModule.conditions)
  • Breast Implant-Associated Anaplastic Large Cell Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.